Bright Minds Biosciences Inc. DRUG
NASDAQ · United States · Health Technology
$50.69+1.48 (+3.01%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-08-17 | -0.17 | -1.22 | +85.8% | $0 | — | +9.9%$76.44→$84.04 |
| Q2 2026 | 2026-05-19 | -1.09 | -1.26 | +13.5% | — | — | +10.4%$75.00→$82.78 |
| Q4 2025 | 2026-02-12 | -0.70 | -0.98 | +28.6% | — | — | 0.0%$77.92→$77.90 |
| Q4 2025 | 2025-12-23 | -0.58 | -1.00 | +42.0% | — | — | +2.0%$83.01→$84.66 |
| Q4 2024 | 2024-12-30 | -0.17 | -0.60 | +71.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.